Comparison between neurectomy and botulinum toxin A injection for denervated skeletal muscle

Journal of Neurotrauma

Volumn 27, Issue 8, 2010, Pages 1509-1516

  Tsai, Feng Chou ^a   Hsieh, Ming Shium ^b   Chou, Chih Ming ^b  

^a Division of Plastic Surgery   (United States)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

apoptosis; botulinum toxin; denervation; neurectomy; skeletal muscle

Indexed keywords

APOPTOSIS INDUCING FACTOR; BOTULINUM TOXIN A; CASPASE 3; CASPASE 9; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; MUSCLE DENERVATION; MUSCLE MASS; NEURECTOMY; NONHUMAN; RAT; REPEATED DRUG DOSE; SARCOMERE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SURVIVAL; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; BOTULINUM TOXINS, TYPE A; CELL SURVIVAL; FEMALE; HUMANS; LEG; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE DENERVATION; MUSCLE, SKELETAL; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SIGNAL TRANSDUCTION;

EID: 77955878372     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1320     Document Type: Article

References (33)

1. Adhihetty, P.J., O'Leary, M.F.N., and Chabi, B. (2007). Effect of denervation on mitochondrially mediated apoptosis in skeletal muscle. J. Appl. Physiol. 102, 1143-1151.
2. Ahn, K.Y., and Kim, S.T. (2007). The change of maximum bite force after botulinum toxin type A injection for treating masseteric hypertrophy. Plast. Reconstr. Surg. 120, 1662-1666.
3. Bain, J.R., Mackinnon, S.E., and Hunter, R.T. (1989). Functional evaluation of complete sciatic, peroneal and posterior tibial nerve lesions in the rat. Plast. Reconstr. Surg. 83, 129-138.
4. Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., and Bauerlein, R. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biology 3, 1014-1019.
5. Chiu, S.M., Xue, L.Y., Usuda, J., Azizuddin, K., and Oleinick, N.L. (2003). Bax is essential for mitochondria-mediated apoptosis but not for cell death caused for photodynamic therapy. Br. J. Cancer 89, 1590-1597.
6. Chuang, D.C. (2009). Adult brachial plexus reconstruction with the level of injury: review and personal experience. Plast. Reconstr. Surg. 124, e359-e369.
7. Davatz, G.C., Andreo, J.C., Rodrigues, A.C., Rosa Junior, G.M., and Moraes, L.H.R. (2007). Apoptosis in denervated skeletal muscle. Int. J. Morphol. 25, 529-536.
8. Ferreira, R., Neuparth, M.J., Vitorino, R., Appell, H.J., Amado, F., and Durate, J.A. (2008). Evidences of apoptosis during the early phases of soleus muscle atrophy in hindlimb suspended mice. Physiol. Res. 57, 601-611.
9. Franke, T.F., Yang, S.I., and Chan, T.O. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of PDGF-activated phosphoinositide 3-kinase. Cell 81, 727-736.
10. Harii, K., and Kawashima, M. (2008). A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects. Aesthetic Plast. Surg. 32, 724-730.
11. Hatoko, M., Niitsuma, K., and Tanaka, A. (2004). Expression of N-Cadherin and a N-Catenin in the degeneration/regeneration process of rat skeletal muscle after nerve injury. J. Reconstr. Microsurg. 20, 267-273. (Pubitemid 38481139)
12. Hoare, B.J., Wallen, M.A., Imms, C., Villanueva, E., Rawicki, H.B., and Carey, L. (2010). Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Syst. Rev. 20, CD003469.
13. Kim, K.S., Byun, Y.S., Kim, Y.J., and Kim, S.T.K. (2009). Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle? Dermatol. Surg. 35, 1902-1907.
14. Jackman, R.W., and Kandarian, S.C. (2004). The molecular basis of skeletal muscle atrophy. Am. J. Physiol. Cell Physiol. 287, 834-843.
15. Jeng, S.F., Rau, C.S., Liliang, P.C., Wu, C.J., Lu, T.H., Chen, Y.H., Lin, C.J., and Hsieh, C.H. (2009). Profiling muscle-specific microRNA expression after peripheral denervation and reinnervation in a rat model. J. Neurotrauma 26, 2345-2553.
16. Lee, C.J., Kim, S.G., Kim, Y.J., Han, J.Y., Choi, S.H., and Lee, S.I. (2007). Electrophysiologic change and facial contour following botulinum toxin A injection in square faces. Plast. Reconstr. Surg. 120, 769-778.
17. Lee, H.J., Lee, D.W., Park, Y.H., Cha, M.K., Kim, H.S., and Ha, S.J. (2004). Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol. Surg. 30, 867-871.
18. Ma, J., Elsaidi, G.A., and Smith, T.L. (2004). Time course of recovery of juvenile skeletal muscle after botulinum toxin A injection: an animal model study. Am. J. Phys. Med. Rehabil. 83, 774-780.
19. Marzetti, E., Hwang, J.C.Y., and Lees, H.A. (2010). Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim. Biophys. Acta. 1800, 235-244.
20. Namikawa, K., Honma, M., and Abe, K. (2000). Akt/protein kinase B prevents injury induced motoneuron death and accelerates axonal regeneration. J. Neurosci. 20, 2875-2886.
21. Pospisilik, J.A., Knauf, C., Joza, N., and Benit, P. (2007). Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131, 476-491.
22. Rogozhin, A.A., Pang, K.K., Bukharaeva, E., Young, C., and Slater, C.R. (2008) Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin Am. J. Physiol. 586, 3163-3182
23. Schwaiger, F.W., Hager, G., and Schmitt, A.B. (2000). Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT). Eur. J. Neurosci. 12, 1165-1176.
24. Shen, J., Ma, J., Lee, C., Smith, B.P., Smith, T.L., Tan, K.H., and Koman, L.A. (2006). How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: study in juvenile rats. J. Orthop. Res. 24, 1128-1135.
25. Siu, P.M., and Always, S.E. (2005). Mitochondria-associated apoptotic signaling in denervated rat skeletal muscle. J. Physiol. 565, 309-323.
26. Song, Y.H., Li, Y., Du, J., Mitch, W.E., Rosenthal, N., and Delafontaine, P. (2005). Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest. 115, 451-458.
27. Tang, H., Cheung, W.M.W., Ip, F.C., and Ip, N.Y. (2000). Identification and characterization of differentially expressed genes in denervated muscle. Mol. Cell Neurosci. 12, 127-140.
28. Terzis, J.K., and Kostopoulos, V.K. (2010). Vascularized nerve grafts for lower extremity nerve reconstruction. Ann. Plast. Surg. 64, 169-176.
29. Tsai, F.C., Mardini, S., Fong, T.H., Kang, J.H., and Chou, C.M. (2008). Selective neurectomy of the gastrocnemius and soleus muscles for calf hypertrophy: an anatomical study and 700 clinical cases. Plast. Reconstr. Surg. 122, 178-187.
30. Vahsen, N., Cande, C., and Briere, J.J. (2004). AIF deficiency compromises oxidative phosphorylation. EMBO J. 23, 4679-4689.
31. Walsh, S., and Midha, R. (2009). Use of stem cells to augment nerve injury repair. Neurosurgery 65, 80-86.
32. White, C.M., Greensmith, L., and Vrbova, G. (2000). Repeated stimuli for axonal growth causes motorneuron death in adult rats: the effect of botulinum toxin followed by partial denervation. Neuroscience 95, 1101-1109.
33. Wissing, S. (2004). An AIF orthologue regulates apoptosis in yeast. J. Cell Biol. 166, 969-974.